Nuformix PLC Sustainability Reports
Nuformix PLC is a pharmaceutical development company utilizing cocrystallisation technologies to discover and develop novel solid forms of existing small molecule drugs. The company mainly targets therapeutic advancements in fibrosis and oncology through drug repurposing.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 2138003XG3H3I2J3BJ24
FIGI: BBG00BNG11W5
5 reports from 2018 to 2024
